# Acurx Pharmaceuticals, Inc. (ACXP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ACXP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -3.94M | $ -1.71B | $ 0 | $ 8.15M |
| 2025 | $ 0 | $ -8.16M | $ -6.95M | $ 0 | $ 5.27M |
| 2024 | $ 0 | $ -14.82M | $ -10.91M | $ 0 | $ 615.1K |
| 2023 | $ 0 | $ -15.76M | $ -10.60M | $ 0 | $ 4.67M |
| 2022 | $ 0 | $ -13.51M | $ -8.43M | $ 0 | $ 7.32M |
| 2021 | $ 0 | $ -15.15M | $ -5.96M | $ 0 | $ 12.41M |
| 2020 | $ 0 | $ -5.86M | $ -4.27M | $ 66.5K | $ 2.70M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.35 |
| Current Ratio | 3.88 |

## Other views

- [Metrics](https://sponda.capital/en/ACXP.md)
- [Charts](https://sponda.capital/en/ACXP/charts.md)
- [Compare](https://sponda.capital/en/ACXP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.